Last reviewed · How we verify
Insulin detemir and pre-meal insulin aspart.
Insulin detemir and pre-meal insulin aspart. is a Small molecule drug developed by University of Florida. It is currently FDA-approved. Also known as: Insulin detemir = Levemir (Novo Nordisk), Insulin aspart = Novolog (Novo Nordisk).
At a glance
| Generic name | Insulin detemir and pre-meal insulin aspart. |
|---|---|
| Also known as | Insulin detemir = Levemir (Novo Nordisk), Insulin aspart = Novolog (Novo Nordisk) |
| Sponsor | University of Florida |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Afrezza® INHALE-1 Study in Pediatrics (PHASE3)
- The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients (PHASE2, PHASE3)
- Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol. (PHASE4)
- Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery (PHASE4)
- The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study (PHASE4)
- Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes (PHASE3)
- Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes (PHASE3)
- A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Insulin detemir and pre-meal insulin aspart. CI brief — competitive landscape report
- Insulin detemir and pre-meal insulin aspart. updates RSS · CI watch RSS
- University of Florida portfolio CI
Frequently asked questions about Insulin detemir and pre-meal insulin aspart.
What is Insulin detemir and pre-meal insulin aspart.?
Insulin detemir and pre-meal insulin aspart. is a Small molecule drug developed by University of Florida.
Who makes Insulin detemir and pre-meal insulin aspart.?
Insulin detemir and pre-meal insulin aspart. is developed and marketed by University of Florida (see full University of Florida pipeline at /company/university-of-florida).
Is Insulin detemir and pre-meal insulin aspart. also known as anything else?
Insulin detemir and pre-meal insulin aspart. is also known as Insulin detemir = Levemir (Novo Nordisk), Insulin aspart = Novolog (Novo Nordisk).
What development phase is Insulin detemir and pre-meal insulin aspart. in?
Insulin detemir and pre-meal insulin aspart. is FDA-approved (marketed).
Related
- Manufacturer: University of Florida — full pipeline
- Also known as: Insulin detemir = Levemir (Novo Nordisk), Insulin aspart = Novolog (Novo Nordisk)
- Compare: Insulin detemir and pre-meal insulin aspart. vs similar drugs
- Pricing: Insulin detemir and pre-meal insulin aspart. cost, discount & access